CLOs on the Move

Stellar Health

www.stellar.health

 
Stellar Health is a healthcare technology company that helps providers and health insurance companies improve quality and financial performance by prompting providers and their practice staff with recommended value-based actions and real-time payments at the point of care. The Stellar platform is a proprietary web-based tool that delivers targeted recommendations designed to meet the new objectives of value-based care delivery models. Stellar Health maintains a culture of compassion, both internally and externally. Their mission is to learn, grow, succeed, and always enjoy the ride.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.stellar.health
  • 215 Park Avenue South 10th Floor
    New York, NY USA 10003
  • Phone: 929.382.4886

Executives

Name Title Contact Details
Samantha Kelen
Chief Compliance Officer Profile

Similar Companies

Westside Health Inc

Westside Health Inc is a Wilmington, DE-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Burgess Health Center

Burgess Health Center is committed to improve the quality of life for the people and communities we serve by providing excellent healthcare and exceptional patient experiences.

AO North America

AO North America is a Paoli, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Milliman Care Guidelines

Milliman Care Guidelines is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Berg LLC

BERG is a Boston-based biopharma company focused on taking a bold “back to biology” approach to therapeutic discovery using its unique AI-based Interrogative Biology® platform. This platform combines patient biology and AI-based analytics to engage the differences between healthy and disease environments. The patient’s own biology drives the platform’s results and guides us in the discovery and development of drugs, diagnostics and healthcare applications. Our platform utilizes patient population health data to bring actionable Patient IntelligenceTM to precision medicine applications. For patients this means faster discovery and development of treatments, more effective precision treatments for individuals as well as a reduction in costs to our healthcare systems. BERG has a robust product portfolio in oncology, endocrinology and neurology with mature assets in oncology entering mid and late stage trials. BERG is committed to improving the lives of patients through precision medicine made possible by our innovative platforms.